Combination of fluoroquinolone antibiotic (levofloxacin) and NSAID (ibuprofen) evaluated for antimicrobial activity and inflammation in a preclinical study.
Target Population
Care Setting
Key Highlights
Combination therapy outperformed monotherapy in microbiological, molecular, and histological endpoints.
Ibuprofen reduced the MIC of levofloxacin by up to eightfold.
Combination treatment showed reduced expression of inflammatory cytokines and downregulated MMP-2 and MMP-9.
Histological analysis revealed near-normal corneal architecture in combination-treated corneas.
Guideline-Based Recommendations
Diagnosis
Evaluate keratitis caused by Staphylococcus aureus.
Management
Consider combination therapy of levofloxacin and ibuprofen based on study findings.
Monitoring & Follow-up
Monitor for corneal complications associated with topical NSAIDs.
Risks
Potential corneal complications with topical NSAIDs.
Patient & Prescribing Data
Patients with bacterial keratitis, particularly those infected with Staphylococcus aureus.
Combination therapy evaluated for targeting infection and inflammation.
Clinical Best Practices
Utilize combination therapy in cases of bacterial keratitis as evaluated in the study.
Evaluate the safety profile of NSAIDs in the context of corneal health.
